Weight Loss Injections Price Comparison UK: What You're Actually Paying For

What the published evidence tells us about the cost landscape

NICE's appraisal of tirzepatide (TA1026) and its earlier recommendation for semaglutide (TA875) both confirmed these are clinically meaningful medicines, but neither is available to most people through the NHS yet. The phased NHS rollout, which began in June 2025 and extends in eligibility tranches through 2027, covers only those who meet strict criteria involving BMI and multiple weight-related conditions. For the majority of adults who qualify on licence but not on NHS criteria, private prescription is the only current route.

That's why a UK price comparison for weight loss injections is genuinely useful. Eli Lilly raised the UK list price of Mounjaro significantly from 1 September 2025, the highest-dose pen's list price moved from around £122 to around £330 for a four-week supply, as widely reported in August 2025. Private providers pass this on at varying margins. Wegovy pricing follows a different structure, and dose-dependent pricing means what you pay at 2.5mg and what you pay at 10mg or 12.5mg can differ substantially. Any honest summary of weight loss injection prices has to account for that escalation.

The figure that tends to appear in search results is the starting-dose price. That's the lowest number on the ladder, which makes for attractive copy. It is also the dose at which almost no one stays long-term.

What a headline price often leaves out

A recurring finding when people compare weight loss injections prices across UK providers is that the quoted monthly figure sometimes covers only the medicine itself. The consultation fee, the prescription charge, delivery, and any ongoing clinical support can all arrive as separate line items, or not arrive at all, which raises its own questions.

Consider what a supervised course of treatment actually requires: an initial clinical assessment, identity verification, at least one dose review before any increase, regular monitoring of weight and response, and a channel for clinical queries when side effects arise. These aren't optional extras. The NHS England guidance on weight management injections is explicit that these medicines should be used alongside clinical support, not posted out in isolation.

Delivery logistics matter too. A pen that requires refrigeration between 2–8°C needs a cold-chain courier. That costs money. Providers who absorb it have built it into the price; those who don't either pass it on or skip it, with obvious consequences for medicine quality on arrival. Worth checking before you compare.

Where nume sits in the comparison, and why

One transparent weight loss injection price covers the consultation, the prescription, the medicine itself, same-day dispatch, next-working-day tracked delivery by DPD, and seven-day-a-week aftercare. There is no subscription. Every repeat order goes back in front of a prescriber (a real clinician reads your answers, not software) and no dose increase is dispensed without clinical review of your response and current weight.

Cheapest isn't a race we entered. That's deliberate. The reason sits in the clinical infrastructure: photo-ID verification, live weight confirmation on video, GP notification in line with GPhC guidance, and evidence checks before each escalation. All of that costs more than a bare-bones fulfilment model, and it should. You can verify our GPhC-registered pharmacy at registration number 9012878.

If you want to dig further into how provider costs break down, the cost comparison breakdown covers the specific line items to interrogate. For context on how prices have shifted since the Lilly list-price increase, the price increase explainer sets out what changed and why.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has been clear about what happens at the bottom of this market. Counterfeit weight loss pens (including fake tirzepatide) have been seized in large volumes from illegal UK supply chains, including from an illicit manufacturing site raided in Northampton in October 2025. Fake pens have in some cases contained insulin. The pricing of those products tends to look competitive until it isn't. The MHRA's Yellow Card scheme allows anyone to report a suspect seller.

For a prescription-only medicine, the right question isn't which provider is cheapest, it's which provider can demonstrate a licensed supply chain, verifiable pharmacy registration, prescriber-led clinical review, and the infrastructure to support you safely through treatment. A small saving on the monthly cost is not the measure that keeps you safe or keeps the medicine working.

Legitimate providers don't offer discount codes for prescription medicines. If a seller is advertising vouchers or promo codes for Mounjaro or Wegovy, that's a meaningful red flag, not a bargain. The page on the cheapest options sets out the safety signals to look for when comparing providers.

Ready to see whether treatment is clinically right for you? The free consultation takes a few minutes, is reviewed the same day, and includes everything from prescription through to the pen arriving in a plain, tracked DPD box the next working day.